DE3873007T2 - Kathartica. - Google Patents

Kathartica.

Info

Publication number
DE3873007T2
DE3873007T2 DE8888308842T DE3873007T DE3873007T2 DE 3873007 T2 DE3873007 T2 DE 3873007T2 DE 8888308842 T DE8888308842 T DE 8888308842T DE 3873007 T DE3873007 T DE 3873007T DE 3873007 T2 DE3873007 T2 DE 3873007T2
Authority
DE
Germany
Prior art keywords
keto
fluoro
group
tetrahydropyranyl
pgs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888308842T
Other languages
German (de)
English (en)
Other versions
DE3873007D1 (de
Inventor
Sachiko Kuno
Tomio Oda
Ryuji Ueno
Ryuzo Ueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
Ueno Seiyaku Oyo Kenkyujo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ueno Seiyaku Oyo Kenkyujo KK filed Critical Ueno Seiyaku Oyo Kenkyujo KK
Application granted granted Critical
Publication of DE3873007D1 publication Critical patent/DE3873007D1/de
Publication of DE3873007T2 publication Critical patent/DE3873007T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Ceramic Products (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
DE8888308842T 1987-10-02 1988-09-23 Kathartica. Expired - Lifetime DE3873007T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25016387 1987-10-02

Publications (2)

Publication Number Publication Date
DE3873007D1 DE3873007D1 (de) 1992-08-27
DE3873007T2 true DE3873007T2 (de) 1992-12-03

Family

ID=17203760

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888308842T Expired - Lifetime DE3873007T2 (de) 1987-10-02 1988-09-23 Kathartica.

Country Status (12)

Country Link
EP (1) EP0310305B1 (enExample)
KR (1) KR930001833B1 (enExample)
AT (1) ATE78465T1 (enExample)
AU (1) AU609883B2 (enExample)
CA (1) CA1312014C (enExample)
DE (1) DE3873007T2 (enExample)
ES (1) ES2051862T3 (enExample)
GB (1) GB2210556B (enExample)
GR (1) GR3005681T3 (enExample)
NZ (1) NZ226362A (enExample)
OA (1) OA09016A (enExample)
ZA (1) ZA887260B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0410646B1 (en) * 1989-07-27 1994-03-02 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Treatment of hyperlipidemia with 15-keto-prostaglandin compounds
US5234954A (en) * 1989-07-27 1993-08-10 K.K. Ueno Seiyaku Oyo Kenkyujo Treatment of hyperlipidemia with 15-keto-prostaglandin compounds
DE69019431T2 (de) * 1989-07-27 1995-09-14 Ueno Seiyaku Oyo Kenkyujo Kk Verwendung von 15-Keto-Prostansäure-Derivaten zur Herstellung eines Medikaments für die Verbesserung der Ausscheidung des Kaliumions.
ATE121624T1 (de) * 1989-08-09 1995-05-15 Ueno Seiyaku Oyo Kenkyujo Kk Verwendung von prostansäurederivaten zur herstellung von arzneimitteln zur verbesserung der ausscheidung von nichtprotein in die därme.
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
CA2030344C (en) 1989-11-22 2000-04-18 Ryuji Ueno Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
US5256696A (en) * 1989-11-22 1993-10-26 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of cardiac dysfunction with 15-ketoprostaglandin compounds
US5254588A (en) * 1989-11-22 1993-10-19 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
TW249226B (enExample) * 1990-04-04 1995-06-11 Aderk Ueno Kk
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
ES2093774T3 (es) * 1991-03-14 1997-01-01 R Tech Ueno Ltd Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina.
CA2150287C (en) * 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
AR026046A1 (es) 1999-10-15 2002-12-26 R Tech Ueno Ltd NUEVA COMPOSICIoN Y MÉTODO PARA ESTABILIZAR LA MISMA
US6414016B1 (en) 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
TWI302100B (en) * 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
ATE387204T1 (de) 2001-05-18 2008-03-15 Sucampo Ag Zusammensetzung mit induzierendem kathartischen effekt
BR0212233A (pt) * 2001-08-31 2004-10-05 Sucampo Ag Abridor de canal de cloreto
AR037524A1 (es) * 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
US7732487B2 (en) 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4410720A (en) * 1973-08-06 1983-10-18 Hoffmann-La Roche Inc. 16-Fluoro prostaglandins
US4163016A (en) * 1977-07-05 1979-07-31 Hoffmann-La Roche Inc. 16-Substituted prostaglandins
JPS5626830A (en) * 1979-08-10 1981-03-16 Kuraray Co Ltd Hydroformylation of lower olefin
US4374856A (en) * 1980-09-10 1983-02-22 The Upjohn Company Liver cytoprotection using PGE's
GB8324004D0 (en) * 1983-09-07 1983-10-12 Erba Farmitalia 16-fluoro-16 17-didehydro prostanoids
GB2202468A (en) * 1987-03-25 1988-09-28 Smidth & Co As F L Cyclone
EP0292177B1 (en) * 1987-05-15 1992-03-25 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Fervescence composition
AU604156B2 (en) * 1988-09-14 1990-12-06 R-Tech Ueno, Ltd. Prostaglandins of the F series

Also Published As

Publication number Publication date
GB8822455D0 (en) 1988-10-26
ZA887260B (en) 1989-06-28
AU609883B2 (en) 1991-05-09
ES2051862T3 (es) 1994-07-01
GB2210556A (en) 1989-06-14
EP0310305B1 (en) 1992-07-22
KR890006241A (ko) 1989-06-12
AU2292088A (en) 1989-04-06
ATE78465T1 (de) 1992-08-15
OA09016A (fr) 1991-03-31
DE3873007D1 (de) 1992-08-27
EP0310305A3 (en) 1989-06-14
KR930001833B1 (ko) 1993-03-15
GB2210556B (en) 1991-07-17
CA1312014C (en) 1992-12-29
GR3005681T3 (enExample) 1993-06-07
NZ226362A (en) 1991-07-26
EP0310305A2 (en) 1989-04-05

Similar Documents

Publication Publication Date Title
DE3873007T2 (de) Kathartica.
DE3876050T2 (de) Okulare hypotensivagenzien.
DE60131547T2 (de) Abführende zusammensetzungen
DE69511181T2 (de) Mittel für Behandlung der Leber-Gallenerkrankungen
DE69129921T2 (de) Behandlung von Katarakt mit 15-keto-Prostaglandinderivaten
EP0299914B2 (de) 9-Halogen-(Z)-prostaglandinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US5317032A (en) Prostaglandin cathartic
DE69028289T2 (de) Verwendung von 15-keto-Prostaglandin zur Verbesserung der encephalischen Funktion
US5194429A (en) Ocular hypotensive agents
DE68928551T2 (de) Oculare hypotensive Mittel
DE60218451T2 (de) 15-ketoprostaglandin-verbindung zur behandlung von azrneimittelinduzierter verstopfung
CH637949A5 (en) Process for the preparation of novel sodium salts of prostaglandin derivatives
DE69213057T2 (de) Stimulierung von Wundheilung mit 15-Keto-prostaglandinverbindungen
US5166178A (en) Ocular hypotensive agents
DE68905241T2 (de) Tracheobronchodilatator.
DE68908950T2 (de) Anwendung von 15-Keto-prostaglandin-E- oder F-Verbindungen für uterine Kontraktionen.
DE69118978T2 (de) Behandlung von entzündlichen Erkrankungen mit 15-Ketoprostaglandinen
DE69105349T2 (de) Behandlung von intraocularem Druck mit einer synergistischen Kombination zur ophthalmischen Verwendung.
KR920007570B1 (ko) 체온 상승제
DE60011748T2 (de) Methoden und zusammenstellungen zur behandlung der weiblichen sexuellen dysfunktion
US6956056B2 (en) Method for providing a cathartic effect
DE69106777T2 (de) Behandlung von intraokularem Druck mit einer ophthalmischen synergistischen Kombination.
DE69116224T2 (de) Behandlung von intraokularem Druck mit einer synergischen Kombination
DE69032000T2 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
DE69417584T2 (de) 7-[carboxyalkyl oder alkenyl]-6-[alkyl oder alkenyl] 3-oxo-2,4-dioxobicyclo-[3.2.1]octan und dessen derivate

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SUCAMPO AG, ZUG, CH